cAMP-Epac—Rap1信号通路在肾脏疾病中的研究进展
被引量:4
摘要
环磷酸腺苷(cAMP)是细胞内广泛存在的第二信号分子,在细胞增殖、分化、凋亡等生理病理过程中具有重要效应。
出处
《中华肾脏病杂志》
CAS
CSCD
北大核心
2012年第6期498-501,共4页
Chinese Journal of Nephrology
基金
国家自然科学基金(30971379)
参考文献44
-
1Zaccolo M, Magalhaes P, Pozzan T. Compartmentalisation of cAMP and Ca (2+) signals. Curr Opin Cell Biol, 2002, 14: 160-166.
-
2Bos JL, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rapl guanine-nucleotide-exchanger factor directly activated by cyclic AMP. Nature, 1998, 396: 474-477.
-
3Bos JL. Epae: a new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol, 2003, 4: 733-738.
-
4Rangarajan S, Enserink JM, Kuiperij HB, et al. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rapl upon stimulation of the beta 2-adrenergic receptor. J Cell Biol, 2003, 160: 487-493.
-
5Fukuhara S, Sakurai A, Sano H, et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rapl signaling pathway. Mol Cell Biol, 2005, 25: 136-146.
-
6Pannekoek WJ, van Dijk JJ, Chan OY, et al. Epacl and PDZ.GEF cooperate in Rapl mediated endothelial junction control, Cell Signal, 2011, 23: 2056-2064.
-
7Li Y, Konings IB, Zhao J, et al. Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2. Am J Physiol Renal Physiol, 2008, 295: F525-F533.
-
8Sun L, Kondeti VK, Xie P, et al. Epacl-Mediated, High Glucose-Induced Renal Proximal Tubular Cells Hypertrophy via the Akt/p21 Pathway. Am J Pathol, 2011, 179: 1706-1718.
-
9Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMP-binding proteins that directly activate Rapl. Science, 1998. 282(5397): 2275-2279.
-
10Kitayama H, Sugimoto Y, Matsuzaki T, et al. A ras-related gene with transformation suppressor activity. Cell, 1989, 56: 77-84.
二级参考文献85
-
1彭炎强,姜宗培,纪玉莲,余学清,高玲,彭文兴,董秀清.NADPH氧化酶抑制剂apocynin对大鼠糖尿病肾小球细胞外基质代谢的影响[J].中华肾脏病杂志,2005,21(9):517-521. 被引量:11
-
2陈晓岚,张晓娟,范亚平,施岚,俞燕.辛伐他汀对大鼠系膜细胞增殖、凋亡及细胞内半胱氨酸天冬氨酸蛋白酶3表达的影响[J].中华肾脏病杂志,2006,22(2):109-113. 被引量:9
-
3韩敏,徐钢,曾锐,刘蔚.β-连环素酪氨酸磷酸化调控E-钙黏蛋白表达参与转化生长因子β1诱导的人肾小管上皮细胞转分化[J].中华肾脏病杂志,2006,22(8):494-498. 被引量:21
-
4Hills CE,Squires PE.TGF-betal-induced epithelial-tomesenchymal transition and therapeutic intervention in diabetic nephropathy.Am J Nephrol,2010,31:68-74.
-
5Hills CE,Al-Rasheed N,Willars GB,et al.C-peptide reverses TGF-beta1 -induced changes in renal proximal tubular cells:implications for treatment of diabetic nephropathy.Am J Physiol Renal Physiol,2009,296:F614-F621.
-
6Morsy MD,Hassan WN,Zalat SI.Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats.Diabetol Metab Syndr,2010,2:29-36.
-
7Sanchez AP,Sharma K.Transcription factors in the pathogenesis of diabetic nephropathy.Expert Rev Mol Med,2009,11:e13-e32.
-
8Koya D,Hayashi K,Kitada M,et al.Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats.J Am Soc Nephrol,2003,14:S250-S253.
-
9Du J,Wang L,Liu X,et al.Janus kinase 2/signal transducers and activators of transcription signal inhibition regulates protective effects of probucol on mesangial cells treated with high glucose.Biol Pharm Bull,2010,33:768-772.
-
10Wang H,Li J,Yu L,et al.Antifibrotic effect of the Chinese herbs,astragalus mongholicus and angelica sinensis,in a rat model of chronic puromycin aminonucleoside nephrosis.Life Sci,2004,74:1645-1658.
共引文献28
-
1张锐,阳晓,李军,伍军,彭文兴,董秀清,余学清.缺血再灌注损伤后大鼠肾小管上皮细胞有机阴离子转运蛋白的表达及其功能[J].中华肾脏病杂志,2008,24(2):119-124. 被引量:1
-
2赖添顺,郭振辉,苏磊,白涛,孙杰,唐柚青.不同潮气量机械通气对ALI犬肾脏的影响[J].广东医学,2008,29(4):539-541.
-
3陈国纯,刘虹,王畅,周循,刘伏友.mTOR通路调控肾间质成纤维细胞活化的机制[J].中华肾脏病杂志,2012,28(3):226-231. 被引量:5
-
4李跃红,陈健,王清华,何计南.普罗布考联合厄贝沙坦治疗糖尿病肾病的疗效观察[J].医学临床研究,2012,29(9):1731-1733. 被引量:3
-
5秦双立,楼迪栋,刘燕斐,于燕妮,官志忠.慢性氟中毒大鼠肾脏细胞线粒体分裂蛋白Fisl表达和线粒体超微结构改变[J].中华地方病学杂志,2013,32(2):125-128. 被引量:1
-
6张研,刘波,王清.普罗布考对糖尿病肾病患者的肾脏保护作用[J].中国现代医学杂志,2013,23(20):60-63. 被引量:6
-
7周乐天,刘伏友.非转移性黑色素瘤糖蛋白B在急性肾缺血再灌注损伤中的表达及与巨噬细胞表型的关系[J].中华肾脏病杂志,2013,29(7):509-514. 被引量:2
-
8赵龙,关广聚.糖尿病肾病发病机制研究进展[J].中华肾脏病杂志,2013,29(7):554-558. 被引量:77
-
9秦双立,官志忠.线粒体损伤和氧化应激的关系[J].国外医学(医学地理分册),2013,34(3):197-201. 被引量:26
-
10贾宁,王汉,郑晶,林琳.复方五味子醇提取液处理对肾小管上皮细胞转分化的影响研究[J].时珍国医国药,2013,24(10):2410-2411.
同被引文献91
-
1Haider R.Cheema,Ahmed Al Habash,Essam Al-Askar.Improvement of visual acuity based on optical coherence tomography patterns following intravitreal bevacizumab treatment in patients with diabetic macular edema[J].International Journal of Ophthalmology(English edition),2014,7(2):251-255. 被引量:3
-
2李雪芹,熊功友,林玲,龚帧,刘建云.百令胶囊与依那普利联合应用对实验性大鼠肾功能的影响[J].中国中药杂志,2004,29(11):1118-1119. 被引量:9
-
3崔美玉.冬虫夏草治疗IgA肾病30例[J].山东中医杂志,1996,15(5):217-217. 被引量:20
-
4周红霞,梅柏如,赵丽萍.慢性肾脏疾病中的脂质代谢异常与肾损伤的关系[J].江苏医药,2007,33(11):1179-1179. 被引量:3
-
5Boer I HD, Rue TC, Cleary PA, et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria:an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort[ J]. Arch Intern Med, 2011,171 (5) :412-420.
-
6Pavkov ME, Knowler WC, Bennett PH, et al. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians[ J]. Kidney Int ,2006,70 (10) : 1840-1846.
-
7Stanton RC. Clinical challenges in diagnosis and management of diabetic kidney disease[J]. Am J Kidney Dis,2014,63(2 Suppl 2) :s3-21.
-
8Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications ( DCCT/EDIC ) Research Group, Nathan DM, Zinman B, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years ' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience( 1983-2005 ) [ J]. Arch Intern Med ,2009,169 ( 14 ) : 1307-1316.
-
9Perkins BA FLH, Roshan B,et al. In patients with type 1 diabetes and new-onsetmicroalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria [ J ]. Kidney Int ,2010,77 ( 1 ) :57-64.
-
10Pezzolesi MG, Jan S, Mychaleckyj JC, et al. Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection[ J]. Semin Nephrol,2010,30(2) : 126-140.
引证文献4
-
1吕佳璇,李月红.糖尿病肾病的研究进展[J].临床内科杂志,2016,33(5):296-299. 被引量:40
-
2赵春霖,黄景文,金莉莉,王秋雨.促胰岛素分泌活性肽对胰岛β细胞作用的分子机制[J].中国细胞生物学学报,2016,38(8):1025-1030. 被引量:4
-
3周梦云,胡小磊,张晓梅.Semaphorin3A及其受体与糖尿病血管并发症的关系[J].国际内分泌代谢杂志,2018,38(1):55-58. 被引量:1
-
4苏亚霞,赵爱华.冬虫夏草治疗免疫球蛋白A肾病作用机制网络药理学研究[J].中国药业,2022,31(13):46-52. 被引量:3
二级引证文献48
-
1王莞秋,王旭.“健脾益肾方”联合西药治疗糖尿病肾病30例临床观察[J].世界最新医学信息文摘,2019,0(99):10-11. 被引量:2
-
2丁秀和,杨燕,王会丽,许玉玲,崔思玲,闫燕,陈琦.2型糖尿病患者视网膜病变与肾脏损害的相关性研究[J].临床内科杂志,2016,33(10):707-708. 被引量:5
-
3万靖,李兰芳,曾姣娥.血清丝氨酸蛋白酶抑制剂、内脂素及踝臂指数与糖尿病肾病的相关性研究[J].临床内科杂志,2016,33(12):848-849. 被引量:2
-
4刘曦,马骏,胡茂通,董细丹,项兰婷,顾倩如,杜转运,陈三妹,陈国荣.姜黄素类似物L6H4对2型糖尿病大鼠肾脏的保护作用[J].中国应用生理学杂志,2017,33(1):11-15. 被引量:4
-
5杨昕艳.厄贝沙坦联合通心络胶囊对早期糖尿病肾病患者肾功能的影响[J].中国初级卫生保健,2017,31(2):79-80. 被引量:5
-
6尹琼丽,王一娜,李梅,洪国保,石成钢,陈燕铭.清肾解毒汤联合西医治疗糖尿病肾小球硬化症疗效及对血、尿生化指标的影响[J].现代中西医结合杂志,2017,26(26):2882-2884. 被引量:4
-
7孔艳华,王金海,周玉森,甘田,王艳燕.抗阻训练对2型糖尿病患者早期糖尿病肾病的影响[J].临床内科杂志,2017,34(7):479-481. 被引量:4
-
8杨颖,高凌.外周静脉血气分析在糖尿病酮症酸中毒及终末期糖尿病肾脏疾病中的应用[J].临床内科杂志,2017,34(8):532-534. 被引量:3
-
9王垚,于博,王煜华.血尿酸水平与血浆致动脉粥样硬化指数与2型糖尿病肾病的相关性研究[J].临床内科杂志,2017,34(8):541-544. 被引量:15
-
10刘思光,徐勤娟,赵亮亮,杨欣茹,张贵民.UPLC法Hilic模式下测定促胰岛素分泌肽类似物(Ex4c)有关物质[J].中国新药杂志,2017,26(20):2396-2400. 被引量:3
-
1张彦选,于立新,付绍杰,刘小友,叶俊生.肾移植术后应用雷帕霉素2年疗效观察[J].广东医学,2008,29(5):859-861. 被引量:3
-
2贾文娟,何强(综述),陈江华(审校).脂联素与慢性肾脏病[J].国际泌尿系统杂志,2011,31(2):226-229.
-
3薛源,许建中.血小板衍生生长因子与骨折愈合[J].中国矫形外科杂志,2005,13(20):1584-1585. 被引量:7
-
4云虹,胡晓云.乳癌手术麻醉方法的临床分析[J].保健医学研究与实践,2009,6(1):33-34.
-
5医学动态[J].中国家庭医生,2008(17):2-2.
-
6董飞侠.胱抑素C的临床意义[J].养生月刊,2013(7).
-
7耿文静,柳方娥,焦波,程艳娜.EPA、DHA对脂多糖诱导的大鼠系膜细胞增殖及凋亡的影响[J].山东大学学报(医学版),2008,46(1):57-59. 被引量:8
-
8连莲.胱抑素C在临床中的应用评价[J].包头医学院学报,2010,26(3):134-135. 被引量:3
-
9杨珍,孔薇.NF-κB与肾脏病的关系[J].河南中医,2014,34(4):772-773. 被引量:3
-
10尤冬梅.胱抑素C的生物学特征及其临床应用[J].山西医药杂志,2015,44(8):895-897. 被引量:8